Blog

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Drug shows encouraging signs for patients of less common type of dementia. Pacific Neuroscience Institute located at Providence Saint John’s Health Center among sites for clinical trial.

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience ( PDF ): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma ( NCT03463265 ) Orbus Therapeutics ( PDF ): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Find out about the new and ongoing neuroscience clinical trials at Pacific Neuroscience Institute, addressing difficult diseases such as brain tumors.

July 22, 2020 is Glioblastoma Awareness Day. Glioblastoma (GBM) is one of the most notorious forms of brain cancer and one of the most challenging malignancies to treat in all of oncology.

Pacific Neuroscience Institute’s Pacific Brain Health Center, an outpatient clinic of the Providence Saint John’s Health Center in Santa Monica, CA, is the site for an IRB approved study from Evoke Neuroscience.

An antiviral and an anti-inflammatory therapy against COVID-19, and convalescent plasma are currently in clinical trials at Providence Saint John’s Health Center in Santa Monica, CA.

A new trial treatment using blood plasma donations from people who have fully recovered from COVID-19 infection may be helpful in treating other patients with COVID-19.